Piramal Pharma Ltd.

NSE: PPLPHARMA | BSE: 543635 | ISIN: INE0DK501011 | Industry: Pharmaceuticals
| Momentum Trap
177.1600 5.17 (3.01%)
NSE Jul 10, 2026 15:31 PM
Volume: 5.3M
 

177.16
3.01%
ICICI Direct
PPL owns 17 development and manufacturing facilities across India, US and UK with capabilities in sterile, API, formulations, drug discovery and manufacturing of nutrition products. The company holds 49% stake in AbbVie Therapeutics, JV with...
Number of FII/FPI investors decreased from 244 to 231 in Mar 2026 qtr
More from Piramal Pharma Ltd.
Recommended